Expands Phillips Medisize’s inhalation drug delivery capabilities.

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxtm, today announced ...

Phillips Medisize adds market-leading inhalation capabilities to its existing suite of drug delivery device design and ...

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRx™, today announced the ...